InsidersTradesSigma
Discover the full record of transactions filed by Leen Ann M., Directeur Scientifique. Director active across 1 companies, notably Allovir, Inc.. Aggregated, 4 filings have been logged. Total volume traded: €6.2m. The latest transaction was disclosed on 12 November 2021 — Cession. Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations
Ann M. Leen is the Chief Scientific Officer at Allovir, Inc. She is responsible for leading the company's research and development initiatives. Leen brings extensive scientific expertise and plays a crucial role in innovation and the development of new treatments. Her leadership contributes to advancing the company's scientific goals.